The subnucleus reticularis dorsalis is involved in antinociception produced by a low dose of naloxone during carrageenan-induced inflammation

Brain Research

Volumn 762, Issue 1-2, 1997, Pages 264-268

  Tsuruoka, Masayoshi ^a   Hiruma, Yukiko ^b   Willis, William D ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Analgesia; Inflammation; Naloxone; Subnucleus reticularis dorsalis

Indexed keywords

CARRAGEENAN; NALOXONE; OPIATE; QUINOLINIC ACID;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HYPERALGESIA; INFLAMMATION; LATERAL RETICULAR NUCLEUS; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ANALGESIA; ANIMALS; CARRAGEENAN; MALE; MEDULLA OBLONGATA; NALOXONE; NARCOTIC ANTAGONISTS; NEURITIS; NOCICEPTORS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RETICULAR FORMATION;

EID: 0030876031     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00509-X     Document Type: Article

References (28)

1. Bernard J.F., Villanueva L., Carroue J., Le Bars D. Efferent projections from the subnucleus reticularis dorsalis (SRD) a Phaseolus vulgaris leucoagglutinin study in the rat. Neurosci. Lett. 116:1990;257-262.
2. Bing Z., Villanueva L., Le Bars D. Ascending pathways in the spinal cord involved in the activation of subnucleus reticularis dorsalis neurons in the medulla of the rat. J. Neurophysiol. 63:1990;424-437.
3. Bouhassira D., Villanueva L., Bing Z., Le Bars D. Involvement of the subnucleus reticularis dorsalis in diffuse noxious inhibitory controls in the rat. Brain Res. 595:1992;353-357.
4. Buchsbaum M.S., Davis G.C., Bunney W.E. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature. 270:1977;620-622.
5. Dickenson A.H., Le Bars D., Besson J.M. Diffuse noxious inhibitory controls (DNIC). Effects on trigeminal nucleus caudalis neurons in the rat. Brain Res. 200:1980;293-305.
6. Dickenson A.H., Le Bars D., Besson J.M. Endogenous opiates and nociception: A possible functional role in both pain inhibition and detection as revealed by intrathecal naloxone. Neurosci. Lett. 24:1981;161-164.
7. Ferreira S.H., Nakamura M. Prostaglandin hyperalgesia: The peripheral analgesic activity of morphine, enkephalines and opioid antagonists. Prostaglandins. 18:1979;191-200.
8. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
9. Kamei J., Kawashima N., Kasuya Y. Naloxone-induced analgesia in diabetic mice. Eur. J. Pharmacol. 210:1992;339-341.
10. Kayser V., Guilbaud G. Dose-dependent analgesic and hyperalgesic effects of systemic naloxone in arthritic rats. Brain Res. 226:1981;344-348.
11. Kayser V., Guilbaud G. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain. 41:1990;353-363.
12. V. Kayser, J.M. Besson, G. Guilbaud, Paradoxical effects of low doses of naloxone in experimental models of inflammatory pain, in: H.L. Fields, J.M. Besson (Eds.), Progress in Brain Research, Elsevier Science Publishers B.V., Amsterdam, 1988, pp. 301-312.
13. Lasagna L. Drug interaction in the field of analgesic therapy. Proc. R. Soc. Med. 58:1965;978-983.
14. Le Bars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn covergent neurons in the rat. Pain. 6:1979;283-304.
15. Le Bars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non convergent neurons, supraspinal involvement and theoretical implications. Pain. 6:1979;305-327.
16. Le Bars D., Villanueva L. Electrophysiological evidence for the activation of descending inhibitory controls by nociceptive affrent pathways. Prog. Brain Res. 77:1988;275-299.
17. Levine J.D., Gordon N.C. Method of administration determines the effects of naloxone on pain. Brain Res. 365:1986;377-385.
18. Levine J.D., Gordon N.C., Fields H.L. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature. 278:1979;740-741.
19. Noble F., Fournie-Zaluski M.-C., Roques B.P. Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation. Neuropharmacology. 33:1994;135-140.
20. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
21. Rios L., Jacob J.J.C. Inhibition of inflammatory pain by naloxone and its N methyl quaternary analogue. Life Sci. 31:1982;1209-1212.
22. Rios L., Jacob J.J.C. Local inhibition of inflammatory pain by naloxone and its N-methyl quaternary analogue. Eur. J. Pharmacol. 96:1983;277-283.
23. Swell R.D.E., Spencer P.S.J. Antinociceptive activity of narcotic antagonists and partial agonists, analgesics and other agents in the tail immersion test in mice and rats. Neuropharmacology. 15:1976;683-688.
24. Taiwo Y.O., Basbaum A.I., Perry F., Levine J.D. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor. J. Pharmacol. Exp. Ther. 249:1989;97-100.
25. Ueda H., Fukushima N., Kitao T., Ge M., Takagi H. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Neurosci. Lett. 65:1986;247-252.
26. Villanueva L., De Pommery J., Menetrey D., Le Bars D. Spinal afferent projections to nucleus reticularis dorsalis in the rat. Neurosci. Lett. 134:1991;98-102.
27. Woolf C.J. Analgesia and hyperalgesia produced in the rat by intrathecal naloxone. Brain Res. 189:1980;593-597.
28. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain. 16:1983;109-110.